David Aviezer
2013
In 2013, David Aviezer earned a total compensation of $1.8M as President and Chief Executive Officer at Protalix BioTherapeutics, a 45% decrease compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $213,581 |
| Salary | $527,672 |
| Stock Awards | $870,147 |
| Other | $112,662 |
| Total | $1,774,062 |
Aviezer received $870.1K in stock awards, accounting for 49% of the total pay in 2013.
Aviezer also received $50K in bonus, $213.6K in option awards, $527.7K in salary and $112.7K in other compensation.
Rankings
In 2013, David Aviezer's compensation ranked 4,296th out of 12,286 executives tracked by ExecPay. In other words, Aviezer earned more than 65.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,296 out of 12,286 | 65th |
Division Manufacturing | 1,468 out of 4,612 | 68th |
Major group Chemicals And Allied Products | 409 out of 1,462 | 72nd |
Industry group Drugs | 282 out of 1,156 | 76th |
Industry Biological Products, Except Diagnostic Substances | 41 out of 196 | 79th |
Source: SEC filing on October 9, 2014.
Aviezer's colleagues
We found four more compensation records of executives who worked with David Aviezer at Protalix BioTherapeutics in 2013.
2013
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2013
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2013
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2013
Tzvi Palash
Protalix BioTherapeutics